Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Flows From Operating Activities:    
Net loss $ (2,961,100) $ (1,893,627)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 146,351 69,235
Dividend and interest income (84,162)
Change in fair value of derivative and other accrued liabilities 521 (54,742)
(Benefit)/provision for bad debt (59,170) 9,777
Gain on settlement of debt (310,000)
(Benefit)/provision for slow moving and obsolete inventory (10,878) 123,808
Gain on settlement of accounts payable, net (52,500)
Non-cash compensation:    
Common stock (84,959) 184,295
Options 312,319 (39,290)
Changes in operating assets and liabilities:    
Accounts receivable and other receivables (27,685) (39,119)
Inventory (76,267) (805,220)
Prepaid expenses and other current assets (1,356,043) 102,370
Other assets (879)
Accounts payable and accrued expenses 618,469 (181,790)
Lease liabilities (46,079)
Deferred revenue 215,542 (24,175)
Total Adjustments (452,041) (1,018,230)
Net Cash Used In Operating Activities (3,413,141) (2,911,857)
Cash Flows From Investing Activities:    
Proceeds from sale of marketable securities 1,100,516
Purchases of property and equipment (300,902) (27,392)
Net Cash Provided By (Used In) Investing Activities 799,614 (27,392)
Cash Flows From Financing Activities:    
Payment of financing liability in connection with internal use software (17,989)
Net Cash Used In Financing Activities (17,989)
Net Decrease In Cash (2,631,516) (2,939,249)
Cash - Beginning of Period 3,975,494 15,538,849
Cash - End of Period 1,343,978 12,599,600
Supplemental Disclosures of Cash Flow Information:    
Interest expense
Non-cash investing and financing activities:    
Common stock issued upon conversion of Series D convertible preferred stock 5 5
Return and retirement of common stock (8)
Restricted stock issued in satisfaction of accrued issuable equity 199,888
Change in fair value of marketable securities (181,468) 100,686
Transfer of inventory to property and equipment $ (542,236) $ (44,079)